Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.4.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.58NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.58NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.71NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.71NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CP.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15620.7Singapore
BN.1.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DB.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DB.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CZ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CZ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used